From Metabonomics to Pharmacometabonomics: The Role of Metabolic Profiling in Personalised Medicine
Variable patient responses to drugs are a key issue for medicine and for drug discovery and development. Personalised medicine, that is the selection of medicines for subgroups of patients so as to maximise drug efficacy and minimise toxicity, is a key goal of 21st century healthcare. Currently, mos...
Saved in:
Main Author: | Jeremy Everett (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2016-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacometabonomic association of cyclophosphamide 4‐hydroxylation in hematopoietic cell transplant recipients
by: Jeannine S. McCune, et al.
Published: (2022) -
Assessing the Effectiveness of Direct Data Merging Strategy in Long-Term and Large-Scale Pharmacometabonomics
by: Xuejiao Cui, et al.
Published: (2019) -
The Role of Shared Decision-Making in Personalised Medicine: Opening the Debate
by: Hector Guadalajara, et al.
Published: (2022) -
Personalised cancer medicine Future crafting in the genomic era
by: Kerr, Anne
Published: (2021) -
Personalised cancer medicine Future crafting in the genomic era
by: Kerr, Anne
Published: (2021)